In the present study, the relationship between different serum levels of endogenous testosterone, obesity, and metabolic markers in premenopausal type 2 diabetic women was evaluated for their role in the pathogenesis of diabetes mellitus. A randomized cross-sectional study of total of 66 premenopausal women with T2DM was allocated into three groups with high level, low level, and near-normal fasting insulin level. The control group includes 30 women with matched age and whom is diabetes. Free fasting blood glucose (FBG), postprandial blood glucose (PPG) , fasting serum insulin (FSI), glycosylated hemoglobin (HbA1c), total cholesterol, triglyceride (TG), free testosterone (FT), total testosterone (TT), C-peptide protein, and sex hormone binding globulin (SHBG) were measured. All premenopausal T2DM women tended to significant high levels of BMI, HOMA-IR, C-peptide, FBG, HbA1c and PPS compared to controls (P˂0.05) and with significant difference among groups parallel to their endogenous insulin levels. Total testosterone and free testosterone were significantly lower in all premenopausal T2DM women (P˂0.05), but SHBG showed low but non-significant difference among groups. HOMA-IR showed significant correlation with free testosterone in premenopausal T2DM women with high insulin level (P˂0.05), but no significant correlation with total testosterone and SHBG was found among all patients groups. In conclusion, premenopausal T2DM women of matched age and duration of the disease have low levels of SHBG and testosterone, which was correlated to insulin resistance in hyperinsulinemic women only.
Introduction
Diadetes Mellitus is associated with different metabolic disorders especially type 2 DM which is the most common form.It is a multifaceted and heterogeneous metabolic syndrome. Most patients with type 2 DM are obese with varying degrees of gender-related adiposity and fat tissue distribution 1, 2, 3 . Obesity is a well known indirect risk for type 2DM and cardiovascular disease because of its association with insulin resistance, and consequent glycemic control impairment 4 . Recently, a great concern was paid in respect to the role of testosterone and adipose tissue hormones in the development of insulin resistance, hyperlipidemia, and cardiovascular complications 5 ; and more recent data suggest that androgenemia and central obesity are strong candidates for therapeutic intervention 6, 7 .
Studies have shown that sex-steroid hormones, testosterone and estradiol, exhibit a sex-dimorphic profile wherein age and obesity are associated with decreased testosterone levels in men and increased levels in women 8 . Moreover, evidence exhibited that most obese type 2 diabetic women are hyperandrogenemic with elevated total and free testosterone levels many of whom exhibit signs of increased virility, dyslipidemia and cardiovascular risk 9, 10 .
Cumulative evidence pertaining to the effect of Testosterone on glycemic control has demonstrated that hyperandrogenemia, through impairment of insulin stimulated glucose uptake due to post-receptor defects in signal transduction, induces and is .
All those evidence show a distinced role of androgens in regulating insulin resistance in pre-and post menopausal type2 diabetic women , and the effect of hyperandrogenemia in the pathogenesis of diabetes and its cardiovascular risk.
Patients and methods

Study population
This was a randomized cross-sectional study conducted between Serum total cholesterol and TG concentrations were determined using the enzymatic method with readymade kit (Rflotron plus (ROSCH)-Germany). With the stored frozen samples; SHBG and total and free testosterone levels were measured using ELISA kit (DRG-international Inc USA).
The SHBG was measured for premenopausal women with the normal and high insulin level only, because no serum samples were left for women with the low insulin level.
Statistical Analysis
Statistical analysis was performed using Microsoft Excel 2007 and SPSS computer software version 19. Values were presented as mean ± SD. Baseline characteristics were compared using one-way ANOVA. Pearson correlation coefficients (r) were calculated to evaluate the association between testosterone, SHBG, FSI, FBG, PPG, HbA1c, C-peptide, BMI, total cholesterol, TG, and IR among patient groups. P-value ˂ 0.05 were considered statistically significant. The correlation between HOMA-IR and fasting serum insulin level with lipid profile (total cholesterol and TG) was shown in table 4, and they were non-significant in all patients groups (P>0.01), except in group II patients with the low insulin level, HOMA-IR was significantly correlated with total cholesterol (P<0.05). 
Results
Discussions
In type 2 DM, defect in insulin secretion, tissue resistance to insulin and abnormalities in adipose tissue metabolism are the major observed causes 16 . There is no previous study that was undertaken to navigate and address the association between different endogenous insulin levels with serum testosterone, obesity markers, and glycemic markers in premenopausal type 2 diabetic women..The current study showed significant high levels in adiposity markers and metabolic factors among premenopausal T2DM women with high, near normal, and low insulin levels of matched age and duration of diabetes compared to control subjects All of patients enrolled in this study was either overweight or obese patient with BMI higher than control subjects. Given that there is a complex relationship between obesity, insulin, the apparently healthy HbA1c were all significantly higher than control subjects in an opposite order to insulin levels, and the FBG was directly correlated with insulin resistance in all patient groups, which was significantly higher in hyperinsulinemic women, which is agreed by previous studies in premenopausal T2DM women 18, 19 .
In diabetes, the β-cell dysfunction and inadequet secretion of insulin will lead to an increase in fasting and postprandial glucose level as a result of inadequet suppression of hepatic gloconeogenesis and reduced liver and muscle glucose uptake 20 , this will express higher HOMA-IR in diabetic women compared to their controls.
Dyslipidemia is very common in patients with T2DM, and insulin regulates several steps of lipid metabolism. In the present study, TG level was significantly higher, and cholesterol level was significantly lower in all patient groups.
In women, the menopause effect on visceral tissue is due to higher bioavailable testosterone (or lower SHBG) and it is independent of age, total body adiposity, and cardiovascular risk factors, also the effect of bioavailable testosterone on visceral fat is only partially mediated by insulin resistance 18 .
It is documented that testosterone plays a significant role in obesity, glucose homeostasis, and lipid metabolism, which may have an etiology role in diabetes 21 . This may be true only for women with hypergonadism according to currently available studies, when high total testosterone is corrected, improvement of IR and metabolic syndrome is clear 22, 23 .
Several cross-sectional and prospective studied observed low levels of testosterone in men and high levels of bioavailable testosterone in women with T2DM 24, 25, 26 , and that testosterone level is not affected by the menopause state in women 27 . Additionaly, diabetic premenopausal women with normal body weight show higher levels of free testosterone compared to healthy premenopausal women of matched body weight.. Also, non-diabetic obese women showed the higher free testosterone level than levels estimated in non-diabetic non-obese premenopausal women 28 .
Inversely, other studies did not show high level of testosterone in T2DM women, mainly after adjusting the BMI and insulin resistance 29, 30 .The present study showed the significant low level of total and free testosterone in diabetic premenopausal women with different insulin levels compared to controls, which is not in agreement with the above controversy.
Rashmi et al documented that the total testosterone, FT, and SHBG was inversely correlated with BMI in T2DM patients 29 , also there is an inverse correlation between the amount of visceral fat and plasma insulin; and levels of testosterone and SHBG exhibited same 30, 31 , which partly explain the low level of TT and FT in overweight and obese T2DM women enrolled in this study.
In some studies including pre and post menopausal women showed no change in serum testosterone level in it , s association with increase in BMI or central obesity 32 , or an increase in testosterone level with the increase in obesity 33 . But the majority of studies . Other studies revealed no significant correlations between BMI and serum free testosterone concentrations were observed in diabetic premenopausal women 35, 28 .In the present study, we found a significant correlation between free testosterone ( but not total testosterone) with the insulin resistance in premenopausal T2DM women with hyperinsulimenia (P˂0.05). Previous study suggests that insulin resistance largely mediates the association of free testosterone with diabetes in premenopausal women with hyperinsulinemia, however, the biological mechanism of the testosterone-insulin resistance association is uncertain 36 . Jee-Young et al found significant correlation of testosterone with fasting insulin and HOMA-IR in older T2DM women (P˂0.05) 25 . And the hazard ratio of developing incidence of diabetes were greater for post-menopausal women with higher bioavailable T and lower SHBG (P˂0.01) 30 . Additionally, a cohort study found that the FT levels were positively correlated with BMI, insulin, and glycemia
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. Still, the role of adiposity in the association of T and insulin resistance was not clear by many studies 37, 38, 39 .The present study revelaed the low level of SHBG in premenopausal T2DM women with different insulin levels compared to control subjects, although non-significant (P˃0.05). This result is in line with the systemic review and meta-analysis done by Ding et al who found a protective effect of higher levels of SHBG and incidence of diabetes more in female than in male 8 , independently of metabolic parameters such as insulin resistance 40 . But the relationship between SHBG and fasting insulin and/or insulin resistance is still under controversy 41, 42 . In this study, no significant correlation was found between SHBG and fasting insulin or insulin resistance in premenopausal women with both near-normal and high insulin levels.
In a 3 years prospective study, Bonnet et al agreed that the SHBG was significantly associated with hyperglycemia and was negatively correlated with HOMA-IR and fasting insulin 26 . Moreover, Onat et al found a negative correlation between SHBG and HOMA-IR, fasting glucose level and thus inversely correlated with insulin resistance 43 , and this inverse correlation was stronger in premenopausal women than in postmenopausal 44 . These suggest that variation in these adipose hormones resulting from lower SHBG levels, and to a lower extent from androgenicity, may contribute to metabolic and cardiovascular outcomes during midlife in women 40 .
Conclusions
The present study exhibited that premenopausal T2DM women of matched age and duration of the disease have low levels of SHBG and testosterone, which was correlated to insulin resistance in hyperinsulinemic women only. Large-scale prospective study is warranted to navigate the changes in the endogenous sex hormone from the early stages of diabetes in respect to variable insulin levels in premenopausal T2DM women.
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